- Drug Pipelines
- July 2020
- 36 Pages
Global
From €1930EUR$2,000USD£1,656GBP
- Drug Pipelines
- March 2021
Global
From €1930EUR$2,000USD£1,656GBP
Acotiamide is a drug used to treat functional dyspepsia, a condition characterized by chronic or recurrent upper abdominal pain or discomfort. It is a prokinetic agent, meaning it helps to stimulate the movement of the stomach and intestines. Acotiamide is approved for use in Japan and South Korea, and is currently undergoing clinical trials in the United States.
Acotiamide is part of a larger class of drugs known as gastrointestinal drugs, which are used to treat a variety of conditions related to the digestive system. These drugs can be used to treat conditions such as irritable bowel syndrome, gastroesophageal reflux disease, and peptic ulcers.
The acotiamide market is a relatively small but growing segment of the gastrointestinal drugs market. It is primarily used in Japan and South Korea, but is gaining traction in other countries as well.
Some companies in the acotiamide market include Eisai Co., Ltd., Takeda Pharmaceutical Company, and Daiichi Sankyo Company, Ltd. Show Less Read more